Home > Browse Research > Life Sciences > Biotechnology

Biotechnology: market research reports

The biotechnology industry encompasses the spectrum of life science-based research companies developing products and services for a wide variety of industries and applications. The industry holds the promise of transformative technologies from agriculture to materials science to environmental science to medicine. In agriculture, biotech products enhance crop yield, advance the nutritional value and quality of crops and livestock, and improve the efficacy and safety of pesticides.

In material science, biotechnology is adding to advances in polymer science and the coatings industry. In environmental science, biotech has contributed innovative solutions to environmental clean-up and waste management.

The biggest direct impact of biotechnology, and the biggest market for its products, is in medicine and healthcare. The biotechnology industry is, in many ways, becoming the research and development engine of the pharmaceutical industry. The tools and techniques of genetic analysis and manipulation are at the heart of the drug discovery process, and many of the largest biotech firms have been transformed over the past decade into pharmaceutical and biopharmaceutical giants.

The biotechnology category covers the companies, technologies, tools, and applications of the advanced life science sector. Included are reports on research methods and equipment such as liquid chromatography, mass spectroscopy, genetic sequencing, gene expression, etc. There are also reports on the business of biotechnology, mergers & acquisitions, and funding. Insofar as the sector intersects with the pharmaceutical industry, there are also reports on product pipelines, strategies for drug development and manufacturing such as biogenerics, biosimilars and biomanufacturing. Reports cover so-called green- and white-biotech sectors as well.

Agriculture GMO (182)

Antibody Technologies (225)

Antisense & RNAi Technology (79)

Biologics (65)

Biomarkers (126)

Biomaterials (196)

Biotechnology Company Reports (3262)

Cell Culture (43)

DNA Sequencing (48)

Drug Development (53)

Emerging Technology (113)

Environmental/Industrial Biotechnology (42)

Enzymes (111)

Gene Therapy (34)

General Biotechnology (271)

Genetic Engineering (29)

Genomics (301)

Informatics (60)

Instrumentation & Equipment (255)

Microarray (31)

Molecular Biology (67)

Nanomedicine (71)

Personalized Medicine (55)

Proteomics (120)

Regenerative Medicine (20)

Regulation & Bioethics (24)

Research & Development (456)

Stem Cell (109)

Tissue Engineering (31)

Biotechnology market research reports and industry analysis

Conference Documentation: Biobanking 6/24/2013 \| published by: SMI Publishing, Ltd ... more personalised medicines, acquiring high quality biospecimens is essential. This is reflected in the estimation that the global Biobanking market is expected to reach $183 billion in the next 5 years as biobanks experience rapid ... \| read more...	$788.78
Food Enzymes Market By Types (Carbohydrase, Protease, Lipase), Applications (Beverages, Dairy, Bakery), Sources (Microorganisms, Plants, Animals) & Geography - Global Trends & Forecasts To 2018 6/18/2013 \| published by: MarketsandMarkets ... These are primarily involved in conversion of carbohydrate to carbohydrase, protein to protease, and lipid to lipase. Food enzymes such as carbohydrase, protease, and lipase have anti-staling, digestive, and softening properties, which increase the shelf ... \| read more...	$4,650.00
2013 Analysis of the Cell Surface Markers in Europe: Hospitals, Commercial Labs, Ambulatory Care Centers 6/17/2013 \| published by: Venture Planning Group ... for CD4, CD8, CD34 and other markers by country. Rationale The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor ... \| read more...	$3,850.00
2013 Analysis of the Cell Surface Markers in the US: Hospitals, Commercial Labs, Ambulatory Care Centers, Physician Offices 6/17/2013 \| published by: Venture Planning Group ... with flow cytometry is further expanding the applications of both technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis ... \| read more...	$2,250.00
Biotechnology Product Manufacturing 6/17/2013 \| published by: First Research, Inc. ... Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), and Monsanto; Cangene (Canada) and ADIMMUNE (Taiwan); and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). The global biotechnology industry includes about ... \| read more...	$129.00
Lab Automation Market by Equipment & Software (Automated Liquid Handling & Robotics, Microplate Readers, LIMS and Automated Storage), and Applications (Drug Discovery, Clinical Diagnostics, Genomics, Proteomics) – Trends & Global Forecasts to 2017 6/14/2013 \| published by: MarketsandMarkets ... automation is defined as the use of technology to streamline or substitute manual manipulation of equipment and processes. Laboratory automation offers technologies and engineering backing for state-of-the-art work flows in research, quality assurance, and diagnostics ... \| read more...	$4,650.00
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) 6/13/2013 \| published by: Renub Research ... as well and slowly becoming the reality of future in the diagnostics industry By Technology Segment - Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 ... \| read more...	$1,400.00
Triple Analysis: Melanoma, Antibodies and Peptides 6/12/2013 \| published by: BioSeeker Group AB ... five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas. ... \| read more...	$5,175.00
Triple Analysis: Melanoma, Cancer Vaccines and Antibodies 6/12/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| read more...	$5,175.00
Melanoma Drug Development Analysis: From First-in-Class to Best-in-Class? 6/12/2013 \| published by: BioSeeker Group AB ... setting the path? What is first-in-class in the melanoma pipeline? Is First-in-Class the Best-in-Class? Indication expansion opportunities Drug repositioning opportunities Which pathways are targeted, by what and how? Locate the right drugs to benchmark against ... \| read more...	$2,925.00
Triple Analysis: Melanoma, Pancreatic Cancer and Antibodies 6/12/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| read more...	$5,175.00
Triple Analysis: Melanoma, Protein Kinase Inhibitors and Antibodies 6/12/2013 \| published by: BioSeeker Group AB ... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ... \| read more...	$5,175.00
Novartis Consumer Health OOO in Consumer Health (Russia) 6/11/2013 \| published by: Euromonitor International ... in Russia in the forecast period. This will not only allow the company to reduce production and distribution costs and reduce the impact of currency fluctuations, but will also allow it to widen its research ... \| read more...	$150.00
Bioinformatics in IVD Testing 6/7/2013 \| published by: Kalorama Information ... test interpretation. This report, Bioinformatics in IVD Testing looks at the various IVD market segments where bionformatics is expected to have the most impact. Bioinformatics-based testing has made a huge contribution to cancer diagnosis ... \| read more...	$1,995.00
China Chemical Reagent & Catalysts Mfg. Industry Profile - CIC2661 6/7/2013 \| published by: Beijing Zeefer Consulting Ltd. ... form of data map, the report provides key data and concise analyses on the chemical reagent & catalysts mfg. industry in China, a list of major 20 enterprises in the sector as well as the ... \| read more...	$580.00
Companion Diagnostics Market, 2012-2023 6/6/2013 \| published by: Roots Analysis Pvt. Ltd. ... potential abnormalities and tailoring the treatment so as to make it as individualised as the disease itself. Targeted drugs have been fast to overshadow the traditional drugs, which favour the concept of one-size-fits-all. This has ... \| read more...	$1,699.00
Conference Documentation: RNA Therapeutics 6/5/2013 \| published by: SMI Publishing, Ltd ... the key to the eradication of a number of diseases. SMi’s 2013 RNA Therapeutics conference will look to discuss and share some of the latest findings and research in the field of RNAi technologies and ... \| read more...	$788.78
Polymerase Chain Reaction (PCR) In Medical Application - An Analytical Report, 2009-2015 6/3/2013 \| published by: Axis Research Mind ... for the analysis period, 2009-2015. North America is estimated as the largest market with a market share of 40% of global market and projects US$10.7 billion by end-2010. Europe and Asia-Pacific together account for more ... \| read more...	$4,600.00
Polymerase Chain Reaction (PCR) - Products/Tools - A Global Market Watch, 2009-2015 6/3/2013 \| published by: Axis Research Mind ... for the analysis period, 2009-2015. North America is estimated as the largest market with a market share of 40% of global market and projects US$10.7 billion by end-2010. Europe and Asia-Pacific together account for more ... \| read more...	$2,600.00
Global Markets for Orphan Drugs – Focus on Biologics 6/1/2013 \| published by: BCC Research ... Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017. Detailed discussion of successful orphan products. Detailed analysis of blockbuster orphan drugs. The rising ... \| read more...	$4,400.00
Alkermes Partnering 2005-2013 6/1/2013 \| published by: Current Partnering ... understand Alkermes and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The ... \| read more...	$995.00
Genmab Partnering 2005-2013 6/1/2013 \| published by: Current Partnering ... understand Genmab and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The ... \| read more...	$995.00
Anika Therapeutics Partnering 2005-2013 6/1/2013 \| published by: Current Partnering ... better understand Anika Therapeutics and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company ... \| read more...	$995.00
Global Bioinformatics Market Forecast to 2017 6/1/2013 \| published by: RNCOS ... huge commercial market for bioinformatics worldwide. Over the past decade, the bioinformatics market has significantly evolved across the globe on the back of rising genomics industry. In their latest research study, “Global Bioinformatics Market Forecast ... \| read more...	$1,400.00
Monoclonal Antibodies Partnering Terms and Agreements 6/1/2013 \| published by: Current Partnering ... to license the licensors monoclonal antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest monoclonal antibody deals announced in the healthcare ... \| read more...	$3,795.00

< prev 1 2 3 4 5 6 7 8 9 10 next >